Search results
Is Moderna, Inc. (NASDAQ:MRNA) Trading At A 43% Discount?
Simply Wall St. via Yahoo Finance· 8 hours agoKey Insights The projected fair value for Moderna is US$294 based on 2 Stage Free Cash Flow to...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 1 day agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting
Digital Journal· 3 days agoPRESS RELEASE Published May 22, 2024 ACCESSWIRE Moderna to host an investor event via webcast on Monday, June 3 at 6:15 PM CDT CAMBRIDGE, MA / ACCESSWIRE / May 22, 2024 / ...
Moderna, CureVac, other vaccine stocks jump as new human bird-flu cases reported in U.S., Australia
Market Watch· 3 days agoVaccine-related stocks moved sharply higher Wednesday as new human bird-flu cases were reported in...
Moderna director Afeyan sells over $2.3 million in company stock By Investing.com
Investing.com· 23 hours agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has sold a portion of his holdings in the...
Moderna Has Big AI News. Is the Stock a Buy?
Motley Fool via Yahoo Finance· 3 days agoModerna (NASDAQ: MRNA) isn't new to artificial intelligence (AI). The biotech best known for its billion-dollar coronavirus vaccine has been using this...
Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks
The Wall Street Journal· 2 days agoModerna, BioNTech, CureVac and Novavax have added billions of dollars in combined market...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 3 days agoFEATURE Moderna and Pfizer are in talks with the federal government over a potential avian flu...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 1 day agoShares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and...
Moderna’s long Covid plan
Politico· 2 days agoModerna is eyeing a new target: long Covid. The pharmaceutical company that became a household name when it developed a Covid-19 vaccine now wants to...